Lessons and Challenges for Measles Control from Unexpected Large Outbreak, Malawi
Andrea Minetti , Matthew Kagoli, Agnes Katsulukuta, Helena Huerga, Amber Featherstone, Hazel Chiotcha, Delphine Noel, Cameron Bopp, Laurent Sury, Renzo Fricke, Marta Iscla, Northan Hurtado, Tanya Ducomble, Sarala Nicholas, Storn Kabuluzi, Rebecca F. Grais, and Francisco J. Luquero
Author affiliations: Author affiliations: Epicentre, Paris, France (A. Minetti, H. Huerga, D. Noel, S. Nicholas, R.F Grais, F.J. Luquero); Ministry of Health, Lilongwe, Malawi (M. Kagoli, A. Katsulukuta, S. Kabuluzi); Médecins Sans Frontières, Lilongwe (A. Featherstone, H. Chiotcha, C. Bopp); Médecins Sans Frontières, Paris, France (L. Sury, N. Hurtado); Médecins Sans Frontières, Brussels, Belgium (R. Fricke, T. Ducomble); Médecins Sans Frontières, Barcelona, Spain (M. Iscla)
Figure 3. . Age distribution of children with measles reported in Malawi, 2010. Vaccine-induced immunity of children in age groups vaccinated mostly through a 2-dose vaccination strategy, whether they have been offered 1 dose of vaccine (2 years, 21–30 years of age) or 2 doses of vaccine (3–20 years of age) and natural immunity of children in age groups mostly immunized through natural infection (>31 years of age). Black bars, no vaccine offered; gray bars, 1 vaccine dose offered; white bars, 2 vaccine doses offered.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.